Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,61472,Aia1,Adjuvant induced arthritis QTL 1,18,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),20,3151815,6896013,Rat,n/a,region,qtl 1000,2317057,Aia27,Adjuvant induced arthritis QTL 27,2.83,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),20,3402111,27968216,Rat,n/a,region,qtl 1000,2317851,Alcrsp22,Alcohol response QTL 22,3.2,0.05,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),20,1,26305996,Rat,n/a,region,qtl 1000,1641893,Alcrsp7,Alcohol response QTL 7,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),20,1,26305996,Rat,n/a,region,qtl 1000,724519,Bp144,Blood pressure QTL 144,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),20,1,5192000,Rat,n/a,region,qtl 1000,6893685,Bw111,Body weight QTL 111,2.7,0.004,body mass (VT:0001259),body weight (CMO:0000012),20,1,33300419,Rat,n/a,region,qtl 1000,8694189,Bw153,Body weight QTL 153,3.13,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),20,1,28375393,Rat,n/a,region,qtl 1000,61448,Ciaa1,CIA Autoantibody QTL 1,30,0.001,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),20,3151815,6896013,Rat,n/a,region,qtl 1000,1641915,Colcr9,Colorectal carcinoma resistance QTL 9,2.97,0.0024,intestine integrity trait (VT:0010554),benign colorectal tumor number (CMO:0001795),20,2999707,47999707,Rat,n/a,region,qtl 1000,1354642,Despr15,Despair related QTL 15,,0.0027,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),20,1,24652101,Rat,n/a,region,qtl 1000,1600382,Edcs3,Endometrial carcinoma susceptibility QTL3,3.5,0.003,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),20,1,25653396,Rat,n/a,region,qtl 1000,7411650,Foco23,Food consumption QTL 23,20.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),20,1,28375393,Rat,n/a,region,qtl 1000,7411668,Foco32,Food consumption QTL 32,8,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),20,1,37550487,Rat,n/a,region,qtl 1000,2305926,Iddm37,Insulin dependent diabetes mellitus QTL 37,6,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),20,2018654,47018654,Rat,n/a,region,qtl 1000,9589155,Insul32,Insulin level QTL 32,6.38,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),20,1,28375393,Rat,n/a,region,qtl 1000,2306850,Pia40,Pristane induced arthritis QTL 40,,0.0001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),20,2018770,6567419,Rat,n/a,region,qtl 1000,9590252,Scort12,Serum corticosterone level QTL 12,20.46,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),20,1,37550487,Rat,n/a,region,qtl 1000,9590275,Scort15,Serum corticosterone level QTL 15,3.48,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),20,1,28375393,Rat,n/a,region,qtl 1000,9590109,Sffal8,Serum free fatty acids level QTL 8,5.32,0.01,blood free fatty acid amount (VT:0001553),plasma free fatty acids level (CMO:0000546),20,1,28375393,Rat,n/a,region,qtl 1000,7387283,Uae44,Urinary albumin excretion QTL 44,,0.1712,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),20,1,27357423,Rat,n/a,region,qtl